Literature DB >> 2828683

Tissue tropism and target cells of bluetongue virus in the chicken embryo.

L Wang1, M C Kemp, P Roy, E W Collisson.   

Abstract

In situ cytohybridization was used to determine the tissue tropism and target cells for replication of bluetongue virus (BTV) in the developing chicken embryo. Hybridization with a biotinylated probe specific for segment 3 of BTV serotype 17 detected viral replication in embryos inoculated with U.S. serotypes 2, 10, 11, 13, and 17 or sheep blood containing a BTV field strain. At the final stages of infection, when the embryos were hemorrhagic, viral infection could consistently be detected in the brain, kidney, spinal cord, heart, lung, and liver, with the brain and kidney most severely affected. Other tissues, such as the retina, skin, tongue, and intestinal villi, also supported viral replication in some embryos. Greater concentrations of virus tended to be localized within epithelial cells, such as those lining the kidney tubules and tertiary bronchi of the lungs. Kinetics studies with BTV serotypes 11 and 17 and a field strain indicated that within 24 h after inoculation, viral replication occurred initially in the brain and kidney. By 48 h, viral replication was also detected in the lungs, heart, and spinal cord, with the liver being severely infected by 72 h. Low levels of hybridization could be detected in embryos infected with epizootic hemorrhagic disease virus, which is antigenically related to BTV.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2828683      PMCID: PMC253647          DOI: 10.1128/JVI.62.3.887-893.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

1.  Bluetongue in cattle: effects of Culicoides variipennis-transmitted bluetongue virus on pregnant heifers and their calves.

Authors:  A J Luedke; M M Jochim; R H Jones
Journal:  Am J Vet Res       Date:  1977-11       Impact factor: 1.156

2.  Plaque neutralization of bluetongue virus and epizootic hemorrhagic disease virus in BHK21 cells.

Authors:  M M Jochim; S C Jones
Journal:  Am J Vet Res       Date:  1976-11       Impact factor: 1.156

3.  Experimental viral-induced congenital encephalopathies. II. The pathogenesis of bluetongue vaccine virus infection in fetal lambs.

Authors:  B I Osburn; R T Johnson; A M Silverstein; R A Prendergast; M M Jochim; S E Levy
Journal:  Lab Invest       Date:  1971-09       Impact factor: 5.662

4.  Bluetongue virus in white-tailed deer.

Authors:  F C Thomas; D O Trainer
Journal:  Am J Vet Res       Date:  1970-02       Impact factor: 1.156

5.  Direct assay for bluetongue virus by intravascular inoculation of embryonating chicken eggs.

Authors:  N M Foster; A J Leudke
Journal:  Am J Vet Res       Date:  1968-03       Impact factor: 1.156

6.  Experimental viral-induced congenital encephalopathies. I. Pathology of hydranencephaly and porencephaly caused by bluetongue vaccine virus.

Authors:  B I Osburn; A M Silverstein; R A Prendergast; R T Johnson; C J Parshall
Journal:  Lab Invest       Date:  1971-09       Impact factor: 5.662

7.  Determination of nucleic acid sequence homologies and relative concentrations by a dot hybridization procedure.

Authors:  F C Kafatos; C W Jones; A Efstratiadis
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

8.  The nucleic acid and proteins of epizootic haemorrhagic disease virus.

Authors:  H Huismans; C W Bremer; T L Barber
Journal:  Onderstepoort J Vet Res       Date:  1979-06       Impact factor: 1.792

9.  The complete nucleotide sequence of bluetongue virus serotype 1 RNA3 and a comparison with other geographic serotypes from Australia, South Africa and the United States of America, and with other orbivirus isolates.

Authors:  A R Gould
Journal:  Virus Res       Date:  1987-04       Impact factor: 3.303

10.  Bluetongue virus-induced hydranencephaly in cattle.

Authors:  N J MacLachlan; B I Osburn
Journal:  Vet Pathol       Date:  1983-09       Impact factor: 2.221

View more
  8 in total

1.  Detection of bluetongue virus serotype 17 in Culicoides variipennis by nucleic acid blot and sandwich hybridization techniques.

Authors:  R J Schoepp; J F Bray; K E Olson; A el-Hussein; F R Holbrook; C D Blair; P Roy; B J Beaty
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

2.  Teratogenicity of the Palyam serogroup orbiviruses in the embryonated chicken egg model.

Authors:  T Whistler; R Swanepoel
Journal:  Epidemiol Infect       Date:  1991-02       Impact factor: 2.451

3.  Oncolytic bluetongue viruses: promise, progress, and perspectives.

Authors:  Joseph K-K Li
Journal:  Front Microbiol       Date:  2011-03-16       Impact factor: 5.640

4.  Attenuation of Bluetongue Virus (BTV) in an in ovo Model Is Related to the Changes of Viral Genetic Diversity of Cell-Culture Passaged BTV.

Authors:  Fabian Z X Lean; Matthew J Neave; John R White; Jean Payne; Teresa Eastwood; Jemma Bergfeld; Antonio Di Rubbo; Vittoria Stevens; Kelly R Davies; Joanne Devlin; David T Williams; John Bingham
Journal:  Viruses       Date:  2019-05-26       Impact factor: 5.048

5.  Susceptibility of human retinal pigment epithelial cells to different viruses.

Authors:  H P Huemer; C Larcher; W Kirchebner; J Klingenschmid; W Göttinger; E U Irschick
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-03       Impact factor: 3.117

6.  Detection of avian infectious bronchitis viral infection using in situ hybridization and recombinant DNA.

Authors:  E W Collisson; J Z Li; L W Sneed; M L Peters; L Wang
Journal:  Vet Microbiol       Date:  1990-09       Impact factor: 3.293

7.  Comparative analyses of the nucleocapsid genes of several strains of infectious bronchitis virus and other coronaviruses.

Authors:  A K Williams; L Wang; L W Sneed; E W Collisson
Journal:  Virus Res       Date:  1992-09-15       Impact factor: 3.303

8.  Analysis of a hypervariable region in the 3' non-coding end of the infectious bronchitis virus genome.

Authors:  A K Williams; L Wang; L W Sneed; E W Collisson
Journal:  Virus Res       Date:  1993-04       Impact factor: 3.303

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.